Skip to main content

Table 1 Baseline characteristics of total ECMO study population (n = 240)

From: Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery

Characteristics

Total study population (n = 240)

Baseline characteristics at hospital admission

 Age, years, median (IQR)

65 (55–72)

 Male sex, n (%)

172 (72)

 EuroSCORE (additive), points (IQR)

10 (8–13)

 Procedure duration, h:min (IQR)

8:00 (6:08–9:37)

 Hypertension, n (%)

169 (70)

 Diabetes, n (%)

66 (28)

 Hypercholesterolemia, n (%)

125 (52)

 Coronary artery disease, n (%)

124 (52)

Left ventricular ejection fraction

 30–44 %, n (%)

35 (15)

  < 30 %, n (%)

94 (39)

Creatinine, mg/dl (IQR)

1.3 (1.1–1.8)

eGFR, ml/min/1.73 m2 (IQR)

51.3 (38.9–68.5)

Blood urea nitrogen, mg/dl (IQR)

24.2 (18.2–36.1)

Cholesterol, mg/dl (IQR)

143 (104–182)

C-reactive protein, mg/dl (IQR)

1.0 (0.3–4.3)

White blood cells, g/L (IQR)

8.0 (6.1–11.1)

Thrombocytes, G/L (IQR)

188 (134–241)

Liver parameters

 Bilirubin total, mg/dl (IQR)

1.1 (0.6–1.6)

 Alkaline phosphatase, U/L (IQR)

81 (61–110)

 Aspartate transaminase, U/L (IQR)

33 (23–67)

 Alanine transaminase, U/L (IQR)

27 (18–47)

 AST/ALT ratio, n (IQR)

1.3 (0.9–2.1)

 γ-Glutamyl transferase, U/L (IQR)

54 (32–105)

 Albumin, g/L (IQR)

38.6 (30.8–42.4)

 Normotest, % (IQR)

75 (50–94)

Post-ECMO implantation (first 24 h)

 SAPS-3, n (%)

43 (36–51)

 SOFA score, n (IQR)

12 (10–14)

 ECMO flow, L/min (IQR)

3.36 (2.50–4.25)

 ECMO rotation, rpm (IQR)

3000 (2485–3500)

 ECMO gas flow, L/minute (IQR)

2.5 (2.0 − 3.0)

 ECMO FiO2, % (IQR)

70 (60–100)

 ECMO duration, days, median (IQR)

4 (3–7)

Hemodynamic parameters (at ICU admission)

 Mean arterial pressure, mmHg (IQR)

72 (65–79)

 Cardiac output, L/minute

3.9 (2.8–5.1)

 ScVO2, % (IQR)

71 (64–77)

 Central venous pressure, mmHg (IQR)

14 (11–16)

Medication (first 24 h post-ECMO)

 Noradrenaline, n (%)

234 (98)

 Noradrenaline (maximum dose), μg/kg/minute

0.28 (0.13–0.58)

 Dobutamine, n (%)

218 (91)

 Dobutamine (maximum dose), μg/kg/minute

4.78 (2.88–7.14)

 Vasopressin, n (%)

85 (35)

 Vasopressin (maximum dose), U/h (IQR)

3.0 (2.0–4.0)

  1. ALT alanine aminotransferase, AST aspartate aminotransferase, ECMO extracorporeal membrane oxygenation, eGFR estimated glomerular filtration rate, EuroSCORE European System for Cardiac Operative Risk Evaluation, FiO 2 fraction of inspired oxygen, ICU intensive care unit, IQR interquartile range, SAPS Simplified Acute Physiology Score, ScVO 2 central venous oxygen saturation, SOFA Sequential Organ Failure Assessment